Legal & General Group Plc - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 66 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,372
-31.0%
3,371
-14.0%
0.00%
Q2 2023$26,624
+20.0%
3,921
-11.5%
0.00%
Q1 2023$22,194
-70.6%
4,430
-71.4%
0.00%
Q4 2022$75,517
-66.1%
15,4750.0%0.00%
Q3 2022$223,000
-31.4%
15,475
-27.9%
0.00%
Q2 2022$325,000
+173.1%
21,468
+114.7%
0.00%
Q1 2022$119,000
-26.5%
9,9990.0%0.00%
Q4 2021$162,000
-42.6%
9,999
+0.9%
0.00%
Q3 2021$282,000
+73.0%
9,914
+105.2%
0.00%
Q2 2021$163,000
+19.0%
4,831
+6.7%
0.00%
Q1 2021$137,000
-35.4%
4,528
+5.3%
0.00%
Q4 2020$212,000
+27.7%
4,301
-0.9%
0.00%
Q3 2020$166,000
-32.0%
4,342
-23.3%
0.00%
Q2 2020$244,000
+106.8%
5,659
+25.1%
0.00%
Q1 2020$118,000
-32.6%
4,522
-19.2%
0.00%
Q4 2019$175,000
+98.9%
5,599
+65.1%
0.00%
Q3 2019$88,000
+12.8%
3,3920.0%0.00%
Q2 2019$78,000
+178.6%
3,392
+215.8%
0.00%
Q1 2019$28,000
+27.3%
1,0740.0%0.00%
Q4 2018$22,0001,0740.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders